An Activation Marker Finds a Function  by Mitchell, Diana M. & Williams, Matthew A.
Immunity
Previews(Obar et al., 2010). Understanding how IL-
2 collaborates with other cytokines,
inflammatory mediators, and the inputs
from differential TCR signaling in vivo
may be more complex. This is somewhat
hampered by the comparatively small
numbers of virus-specific CD8+ T cells
generated during many viral infections
making in vitro experimental systems an
important complementary approach for
obtaining sufficient material for many
molecular analysis of intrinsic regulation
of T cell differentiation. Although in vitro
systems do not reflect the real-life
complexity of a pathogen infection, they
can provide useful signposts for in vivo
pursuits. The generation of new reporter
systems, mouse lines that delete tran-
scription factors in a cell- or lineage-
specific manner, and reagents for direct
tracking of transcription factors and cyto-
kine expression by T cells in vivo will be
invaluable in unraveling the steps involvedin peripheral T cell differentiation. Identifi-
cation of surface markers alone (e.g., IL-
7R, IL-2R, and KLRG1) provide tools to
move exploration forward but must be
underpinned by a molecular or mecha-
nistic understanding of how different
groups of T cells arise, and how they are
distributed to various tissues in the body
and contribute to immunological protec-
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In this issue of Immunity, Baaten et al. (2010) describe a previously unknown role for CD44 in counteracting
Fas-mediated apoptosis of Th1 effector cells during clonal expansion and allowing their entry into the
memory pool.Upon exposure to an infectious pathogen,
antigen-specific T cells undergo massive
clonal expansion followed by contraction
(shutdown of the immune response) and
the development of long-lived memory
T cells that protect against subsequent
infections. A current focus of study is to
understand the cellular interactions and
molecular signals that promote the ability
of T cells to survive both clonal expan-
sion and immune response shutdown to
successfully enter the memory pool.
Survival during and after clonal expansion
is controlled by extrinsic (e.g., Fas) and
intrinsic (e.g., Bim) death and survival
pathways (Bouillet and O’Reilly, 2009;
Strasser et al., 2009), and the relativeactivity of these pathways is probably
influenced by a variety factors, including
the quality of initial T cell-dendritic cell
(DC) interactions, sustained access to
environmental cues such as growth or
inflammatory mediators and appropriate
trafficking to sites of infection. Because
T cell receptor (TCR)-mediated signals
result in both prosurvival and proapop-
totic signal, these combined factors
allow the immune system to distinguish
between ‘‘wanted’’ and ‘‘unwanted’’
T cell responses and prohibit the entry of
autoimmune or pathologic T cells into
the memory pool.
Perhaps the most commonly used
marker for distinguishing effector andmemory T cells from their naive
counterparts is the cell-surface molecule
CD44. Activated T cells upregulate sur-
face CD44 expression in the earliest
phases of clonal expansion and maintain
high expression permanently thereafter.
However, the functional role of CD44
during the differentiation of effector and
memory T cell responses is less clear.
Reported functions include roles in traf-
ficking and adhesion, activation of T cell
responses, and the delivery of either
survival or death signals to activated
T cells (Nakano et al., 2007; Ponta et al.,
2003; Ruffell and Johnson, 2008). Never-
theless, although CD44 expression by
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Figure 1. CD44 Prevents Fas-Mediated Apoptosis during Th1 Cell Clonal Expansion
After activation in response to influenza infection, Th1 cells upregulate CD44, overcome Fas-induced
death signals, undergo clonal expansion, and populate the memory pool after pathogen clearance.
In the absence of CD44 signals, clonally expanding T cells undergo Fas-mediated apoptosis and fail to
progress to the memory cell pool.
Immunity
Previewsa variety of activated T cell subsets,
defining how it functions has proven
elusive.
In this issue of Immunity, Baaten et al.
(2010) present compelling evidence to
suggest that although T cell-expressed
CD44 is dispensable for the initiation and
trafficking of influenza-specific T helper
1 (Th1) cell responses, its expression is
required for survival during clonal expan-
sion and subsequent entry into the mem-
ory compartment (Figure 1). The authors
chose to study the role of T cell-specific
CD44 expression by utilizing an adoptive
transfer model system in which wild-type
and CD44-deficient Th1 cell responses
to an influenza-expressed model antigen
are analyzed simultaneously in an
otherwise wild-type host. Whereas Th1
cells initially activated by influenza infec-
tion mounted robust recall responses
upon rechallenge, CD44-deficient Th1-
responding cells failed to do so. A closer
look revealed that whereas CD44-defi-
ciency did not impact early expansion,
trafficking, or acquisition of cytokine-
producing effector function by influenza-
specific Th1 cells, CD44-deficient Th1
cells underwent Fas-mediated apoptosis
in the later stages of expansion, leading
to their elimination from the anti-influenza
response. Although all activated T cells
express CD44, the authors found that
only Th1 cell survival depended on CD44
expression. In vitro-generated Th1 cells
relied on CD44 for survival after in vivo10 Immunity 32, January 29, 2010 ª2010 Elstransfer, whereas Th2, Th17, and CD8+
T cells did not.
TCR activation induces both survival
and death pathways in T cells, and the
survival of a responding T cell during
clonal expansion and contraction is a
balance of the two. Although Fas plays
a role in the elimination of effector T cells
during contraction, it is also thought to
play a role in the elimination of unwanted
(e.g., autoimmune) T cell responses
through activation-induced cell death
(AICD), as evidenced by the development
of lymphoproliferative disorders and
spontaneous autoimmunity in its absence
(Strasser et al., 2009). The factors that
promote and/or regulate Fas-mediated
AICD are therefore able to distinguish
between potentially beneficial and harm-
ful T cell activation events. Baaten et al.
found that CD44 expression by activated
Th1 cells prevented Fas-mediated apo-
ptosis, but how this occurred was not
clear. Although one can postulate an indi-
rect role for CD44 expression in bringing
T cells in closer contact with inflammatory
and/or survival cues that can then pre-
vent Fas-mediated death, they found
that signaling through CD44 directly
promoted survival. Treatment of mice
with an agonist CD44 antibody increased
recovery of Th1-responding cells. Fur-
thermore, the survival signal was largely
delivered during the clonal expansion
phase, given that agonist antibody treat-
ment 8 days after infection had no impactevier Inc.on Th1 cell recovery. Additionally, the
authors found that CD44 signaling in Th1
cells was associated with increased
phosphorylated Akt, supporting the con-
clusion that CD44 signaling directly pro-
motes survival in Th1 cells. Alternatively,
CD44 signaling may enhance the ability
of Th1 cells to respond to other external
survival signals.
One remaining question is whether
CD44 delivers a survival signal available
to all activated Th1 cells or whether it is
an environmental sensor that regulates
entry into Fas-mediated AICD. The gly-
cosaminoglycan Hyaluronin (HA) is an
extracellular matrix (ECM) protein and
a known physiological ligand for CD44
(Jackson, 2009), and it is possible that
HA is regulated spatially and/or tempo-
rally during inflammation. Furthermore,
HA fragments generated by hyaluroni-
dases may either promote CD44-medi-
ated survival signals with varying efficacy
or bring T cells in closer proximity to
locales within the ECM or to cells
expressing HA that are beneficial to their
survival. However, Baaten et al. suggest
that this is not the case. Adoptive transfer
of Th1 effector cells into uninfected hosts
reflected a dependence on CD44 for
survival, even when the host itself was
uninfected. Neither continued antigen
presentation nor the inflammatory envi-
ronment induced by influenza infection
was required for a CD44-mediated sur-
vival signal. Instead, CD44 delivered a
Fas-counteracting survival signal to all
Th1 cells that was dependent on their
differentiation state, not the external
cues to which they were subject or the
induction of its ligand during infection.
Because virtually all activated Th1 cells
express CD44, other factors also prob-
ably play a role in determining the
‘‘switch’’ from AICD to continued expan-
sion and survival for any individual clone.
It is important to note that other physio-
logical ligands for CD44 have been
described. Among these, osteopontin
(OPN) is particularly intriguing. OPN is
a widely distributed soluble protein that
increases expression during some types
of inflammation and promotes migration
of several inflammatory cell types,
including macrophages and neutrophils.
Also, OPN has been shown in some
studies to be secreted by Th1 cells and
promote their in vivo responses (Wang
and Denhardt, 2008), leaving an open
Immunity
Previewsquestionas towhether binding toHA,OPN,
or something else drives the prosurvival
effects of CD44. Regardless, the efficacy
with which either HA or OPN bind to the
CD44 receptor is probably dependent
on CD44 splice variants. Although the
current study does not find any evidence
for splice variants of CD44 during the
anti-influenza Th1 cell response, further
studies will be needed to clearly elucidate
the function of CD44 for T cells with
regards to the source and availability of
potential binding partners.
It is surprising to note that the role of
CD44 in promoting survival and limiting
Fas-mediated apoptosis applied only to
the Th1 cell subset. Baaten et al. suggest
that this may be due to differences in Fas
expression and reliance on Fas-mediated
apoptosis, given that in their studies,
Th2 cells expressed less Fas after
in vitro polarization. However, Fas-medi-
ated AICD is not confined to Th1 cells
only (Krammer et al., 2007), and at least
one study found that CTL responses to
acute infection are markedly reduced in
the absence of T cell surface expression
of CD44 (Graham et al., 2007). It maybe necessary to study CD44-deficient
responses in the context of in vivo infec-
tion that polarizes different T cell subsets,
rather than with in vitro-polarized T cells.
However, if CD44 does send a survival
signal that is unique to Th1 cells, is there
a separate or broader role for CD44 in
the generation or survival of effector and
memory T cells? Furthermore, because
CD44 signaling impacted Th1-responding
cells regardless of the continued pres-
ence of antigen and the infectious inflam-
matory environment, one intriguing possi-
bility is that CD44 may impact T cell
survival under basal conditions, such as
in the long-term maintenance of Th1
memory cells. From a practical stand-
point, these findings suggest that manip-
ulation of CD44 signaling may provide
a therapeutic lever to promote entry into
AICD and remove unwanted Th1 cell
clones, particularly in settings of trans-
plant rejection or autoimmunity. A better
understanding of CD44 is needed here,
given that in some systems it has been
show to promote apoptosis rather than
survival (Nakano et al., 2007; Ruffell and
Johnson, 2008). We anticipate that theImmunity 3current study by Baaten et al. will provide
an important framework for addressing
these and other questions.REFERENCES
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In this issue of Immunity, Hegazy et al. (2010) report that in response to lymphocytic choriomeningitis virus
(LCMV) infection, fully differentiated virus-specific Th2 cells can be reprogrammed into GATA-3+T-bet+ cells
capable of producing both interleukin-4 and interferon-g.CD4+ T cells, also know as T helper (Th)
cells, play critical roles in orchestrating
adaptive immune responses to a variety
of infectious pathogens, allergens, and
self-antigens. Based on their functions
and their patterns of cytokine expression,
activated Th cells were initially classified
into two lineages, Th1 and Th2 cells (Mos-
mann and Coffman, 1989). Th1 cells
produce interferon-g (IFN-g) and Th2 cells
produce interleukin-4 (IL-4), IL-5, and
IL-13 as their signature cytokines. TheTh1-Th2 cell paradigm dominated the
field for almost two decades, until Th17
(IL-17-producing Th) cells and iTreg
(inducible regulatory T) cells that are also
differentiated from naive CD4+ T cells
were reported (for review, see Zhu and
Paul, 2008). With the discovery of these
unique CD4+ T lineages, the relationship
among these different Th cell types has
become an important question. Many
reports have shown that although the
phenotypes of differentiated Th1 andTh2 cells are relatively stable, Th17 and
Treg cells, including natural-occurring
regulatory T (nTreg) and iTreg cells, are
plastic (for review, see Zhou et al., 2009).
In this issue of Immunity, Hegazy et al.
(2010) show that well-differentiated Th2
cells can also be ‘‘taught’’ by appropriate
stimuli to produce IFN-g both in vivo and
in vitro.
Early studies of Th1 and Th2 cell clones
implied that these cells are terminally
differentiated (Mosmann and Coffman,2, January 29, 2010 ª2010 Elsevier Inc. 11
